Tegafur and uracil plus leucovorin in advanced colorectal cancer: a phase II trial.
暂无分享,去创建一个
A. Carrato | J. Aparicio | F. Rivera | E. Díaz-Rubio | M. Navarro | E. Aranda | J. Sastre | C. Fernandez-martos | J. J. Bretón | A. Antón-Torres | C. Fernández‐Martos
[1] A. Carrato,et al. Randomized trial comparing monthly low-dose leucovorin and fluorouracil bolus with weekly high-dose 48-hour continuous-infusion fluorouracil for advanced colorectal cancer: a Spanish Cooperative Group for Gastrointestinal Tumor Therapy (TTD) study. , 1998, Annals of oncology : official journal of the European Society for Medical Oncology.
[2] W. Hiddemann,et al. Effective biomodulation by leucovorin of high-dose infusion fluorouracil given as a weekly 24-hour infusion: results of a randomized trial in patients with advanced colorectal cancer. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[3] M. Buyse,et al. Efficacy of intravenous continuous infusion of fluorouracil compared with bolus administration in advanced colorectal cancer. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[4] E. Espinosa,et al. Uracil and tegafur modulated with leucovorin , 1997, Cancer.
[5] P. Rougier,et al. Randomized trial comparing monthly low-dose leucovorin and fluorouracil bolus with bimonthly high-dose leucovorin and fluorouracil bolus plus continuous infusion for advanced colorectal cancer: a French intergroup study. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[6] R. Pazdur. Phase II study of UFT plus leucovorin in colorectal cancer. , 1997, Oncology.
[7] A. Carrato,et al. Outpatient weekly high-dose continuous-infusion 5-fluorouracil plus oral leucovorin in advanced colorectal cancer. A phase II trial. Spanish Cooperative Group for Gastrointestinal Tumor Therapy (TTD). , 1996, Annals of oncology : official journal of the European Society for Medical Oncology.
[8] C. García-Girón,et al. Efficacy of oral tegafur modulation by uracil and leucovorin in advanced colorectal cancer. A phase II study. , 1995, European journal of cancer.
[9] A. Carrato,et al. A phase II trial of weekly high dose continuous infusion 5‐fluorouracil plus oral leucovorin in patients with advanced colorectal cancer , 1995 .
[10] L. Saltz,et al. A fixed‐ratio combination of uracil and ftorafur (UFT) with low dose leucovorin. An active oral regimen for advanced colorectal cancer , 1995, Cancer.
[11] J. Ajani,et al. Phase II trial of uracil and tegafur plus oral leucovorin: an effective oral regimen in the treatment of metastatic colorectal carcinoma. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[12] M. Buyse,et al. Meta-analysis of randomized trials testing the biochemical modulation of fluorouracil by methotrexate in metastatic colorectal cancer , 1994 .
[13] P. Piedbois. Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: evidence in terms of response rate. Advanced Colorectal Cancer Meta-Analysis Project. , 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[14] R. Reznek,et al. Phase II trial of UFT in advanced colorectal and gastric cancer. , 1990, British Journal of Cancer.
[15] I. Barneto,et al. Weekly high-dose infusion of 5-fluorouracil in advanced colorectal cancer. , 1990, European journal of cancer.